Open AccessThe Challenge: Finding the Most Appropriate Statin and Dose for Each Patient
Author(s) -
Joseph L Lillo
Publication year - 2021
Publication title -
the journal of family practice
Language(s) - English
Resource type - Journals
eISSN - 1533-7294
DOI - 10.12788/jfp.0224
Subject(s) - medicine , statin , nocebo effect , clinical practice , clinical trial , nocebo , intensive care medicine , hydroxymethylglutaryl coa reductase inhibitors , physical therapy , alternative medicine , placebo , pathology
KEY TAKEAWAYS• Discontinuing statin therapy results in increased cardiovascular risk.• The nocebo effect is a common reason for perceived statin intolerance.• Statin intolerance is much less commonly reported in clinical trials than in clinicalpractice, suggesting that patient education and other safeguards employed in clinical trials are important to include in clinical practice.• Several strategies are available that can enable continuation of statin therapy in patients who are truly statin-intolerant.